


| Key | % Net Assets |
|---|---|
| 4.5% | |
| 4.4% | |
| 4.4% | |
| 4.0% | |
| 82.7% |
| Name | % Net Assets |
|---|---|
| UBS | 4.5% |
| Novartis | 4.4% |
| BNP Paribas | 4.4% |
| DnB NOR Bank | 4.0% |
| Roche Holding | 3.8% |
| Brenntag | 3.5% |
| Hexagon | 3.5% |
| Assa Abloy | 3.4% |
| Svenska Cellulosa | 3.3% |
| Henkel | 3.3% |
| Key | % Net Assets |
|---|---|
| 20.00% | |
| 18.60% | |
| 17.50% | |
| 16.80% | |
| 16.50% |
| Date | 27-Mar-2025 |
|---|---|
| NAV | 206.60p |
| Currency | GBP |
| Change | -3.10p |
| % | -1.48% |
| YTD change | 21.20p |
| YTD % | 11.43% |
| Fund Inception | 03/10/2003 |
|---|---|
| Fund Manager | Leon Howard-Spink |
| TER | 1.68 (15-Mar-2012) |
| Minimum Investment | |
|---|---|
| Initial | £1000 |
| Additional | n/a |
| Savings | £50 |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | 0.15 |
You are here: research